← Leaderboards
Nitin Joshi
Brigham And Women'S Hospital
$2,325,703
Attributed
$2,775,776
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,775,776 · 3
By mechanism
R01$1,875,630 · 1
R21$900,146 · 2
Top collaborators
- Jeffrey Michael Karp2 shared
- Li Zeng1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Steven C Ghivizzani$7,278,988
- Samuel C Mok$7,260,442
- Peter Libby$39,585,619
- Elizabeth P Henske$25,563,270
- Su Ryon Shin$3,920,565
Others in their field
Other Emerging Leaders on “In Vitro”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
- Tony Moody · Duke University$34,777,314
Research focus
In VitroPublic HealthUnited States National Institutes Of HealthInnovationMissionEngineeringFormulationEvidence BaseExhibitsDrug Delivery SystemsPreventSolventsDrug KineticsKineticsPharmaceutical PreparationsVariantSmall MoleculeKnee JointDegenerative PolyarthritisPropertyJointsAnimalsDrug EfficacyAnakinra
Grant awards (8)
A self-assembled hydrogel with tunable drug release kinetics for preventing osteoarthritis in active joints$369,039
R01 · FY2025 · AR · contact PI
Exploring nano-bio interactions for cell-specific targeting of osteoarthritis$429,384
R21 · FY2024 · AR
A self-assembled hydrogel with tunable drug release kinetics for preventing osteoarthritis in active joints$369,039
R01 · FY2024 · AR · contact PI
Surmounting substance use disorder using an ultra-long acting injectable platform.$214,902
R21 · FY2024 · DA · contact PI
A self-assembled hydrogel with tunable drug release kinetics for preventing osteoarthritis in active joints$380,452
R01 · FY2023 · AR · contact PI
Surmounting substance use disorder using an ultra-long acting injectable platform.$255,860
R21 · FY2023 · DA · contact PI
A self-assembled hydrogel with tunable drug release kinetics for preventing osteoarthritis in active joints$376,648
R01 · FY2022 · AR · contact PI
A self-assembled hydrogel with tunable drug release kinetics for preventing osteoarthritis in active joints$380,452
R01 · FY2021 · AR · contact PI